Member Info for AATHOMOZ

£702M is roughly £1.2BN in today’s money.

Absolutely lovely.

Forget all the morons; they’re just bitter.

They probably sold out too early on SWC too so REALLY angry right now.

Sit and watch this unfold.

Beer will taste good tonight.

Last minute FOMO kicking in

My interpretation is that Type-M are “super” responders, not that the P140 platform is exclusively for Type-M.

Https://audioboom.com/posts/8772192-midweek-takeaway-featuring-tim-mccarthy-ceo-and-dr-sebastien-goudreau-newly-appointed-cso-of

I’d expect more interviews over the weekend too.

Buffa. That’s just not true.

This share is going crazy today. No doubt.

We will find out in 10 mins Michael.

I suspect you’re wrong.

Explicit in there being NO PLACING

Future funding coming from deals

Patent application submitted for 20 year protection

Market worth $110BN+ with little-to-no competition

It’s not going down in value from here!

I wrote a comment earlier saying that’s roughly £1.2BN in today’s money.

A £1.2BN deal for IMM with 500m shares in issue works through at £2.40/share!

But that’s probably getting a bit carried away!!

XV

Because I think without the patent submitted, the potential deal is less valuable.

You now have it in the public domain that it is submitted and the asset is now more valuable with a potential 20 year protection.

He has multiple parties interested and that means his leverage in a negotiation is now far greater (again, he explains in the video).

I would actually expect this chain of events and the deal to come after the patent. And to be fair, that is what they said would happen.

You also must remember that these interviews are scripted and the questions pre-agreed with the interviewer. Immupharma pay for these interviews and therefore control the narrative. The positive of this is that the responses can be scripted and vetted/approved as 'fair and not misleading'. Like the AGM, this stuff is all overseen by a NOMAD (Nominated Advisor) who regulates activity in line with the market rules.

Therefore - you can't simply say what you want and mislead with false information - particularly when it's as bullish as we are seeing from Tim this year (today and back in Q1).

XV.

They have been keeping the details of the "truly ground-breaking" technology under their hat until patent application was submitted. You have to suspect this has just taken a little longer than anticipated. I'm fine with that, in my world at work, things nearly always take a little longer than planned.

Now that the patent application has been submitted with a potential 20 year protection, they can really 'up the ante' with prospective partners.

He was very clear in saying 1. No placing and 2. Future funding will come from deals. Absolutely explicit. You will hear it for yourself.

I genuinely thought a placing was on the cards (as a holder of 2m+ shares) and to some degree I was OK with that given the placing was likely to be at higher levels post-patent application submission. However it's such a positive this isn't the case and very happy to be wrong.

Finally, I suspect any reference to working on deals over the last several months relates to other products in their portfolio - which Tim has always said things like "watch out for a few surprises". However, you have to feel like the priority has been this patent application for P140, and that's certainly where the cash has been spent.

Lolly. Those advanced discussions may well not be related to P140, as you know. You're just being provocative (shock!)

I think it dropped about 4PM and is 30 mins long, so basically no time to digest and make a move.

Should see SP action on open tomorrow.

All transactions after 16:10 we buys, including a £50K lump.

Funny how this board goes relatively quiet when all the morons evacuate.

A few quotes I noted from the interview:

Seb:

1. "Convinced patent will be granted"

2. "Not talked to partners about discovery until patent application submitted"

3. "Jackson Laboratories in USA verified the results"

4. "Opens the door to full remission" (WOW!)

Tim:

1. "In the middle of licence discussions"

2. "Number of parties vying for licencing"

3. "No placing" !!!

4. "Future funding will come from deals" !!!

5. "Truly groundbreaking"

6. "Humira hit peak sales in 2022 of $21.2BN per year...and I'd like to think we have another Humira here...and initial feedback from potential partners supports that"

7. "In P140 we have an extremely safe drug"

Reference: AZN buy Cambridge Antibody Technology for 'Humira' in a deal worth £702M in 2006 (which would be around £1.2BN in today's money)

https://pharmatimes.com/news/astrazeneca_to_buy_cambridge_antibody_tech_996847/

For a bit of fun £1.2BN across 500m shares in issue = £2.40/share

No.

Big pharma will buy on potential OR to simply stop any further development to protect their own pipeline.

HB - tell me you’re holding strong though? This is just the start.

I have 2m shares and holding for gold. I think IMM and P140 will be a huge success and that means today is just a boost.

I do think a placing is on the cards though…but when we thought that might be in the cards at around 1.5p, I’d take it at these levels!

That’s of course if cash is needed - but the Lanstead agreement has under delivered on cash release the last few months because of how low the SP has been on the ratchet mechanism v. benchmark.